Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA Methyltransferase 1 (DNMT1) is a key enzyme responsible for maintaining DNA methylation patterns during cell division. It catalyzes the transfer of methyl groups to cytosine residues in CpG dinucleotides, primarily ensuring that newly synthesized DNA strands retain the same methylation pattern as the parent strand after replication. Aberrant expression or mutation leads to abnormal DNA methylation patterns associated with cancer development and developmental disorders. Several compounds have been identified as potential inhibitors targeting DNMT1’s enzymatic function for therapeutic applications.
Inhibition of DNA methylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Methyltransferase 1.